ES2545597T3 - Composición nutritiva para fomentar el equilibrio de la flora intestinal y para fomentar la salud - Google Patents

Composición nutritiva para fomentar el equilibrio de la flora intestinal y para fomentar la salud Download PDF

Info

Publication number
ES2545597T3
ES2545597T3 ES10779417.4T ES10779417T ES2545597T3 ES 2545597 T3 ES2545597 T3 ES 2545597T3 ES 10779417 T ES10779417 T ES 10779417T ES 2545597 T3 ES2545597 T3 ES 2545597T3
Authority
ES
Spain
Prior art keywords
fos
inulin
promote
fiber
those consisting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10779417.4T
Other languages
English (en)
Spanish (es)
Inventor
Zamzam Roughead (Fariba)
Jalil Benyacoub
Claudia Roessle
Jennifer Rae Mager
Julie Ann Swanson
Norman Alan Greenberg
Douglas Richard Bolster
Clara Lucia Garcia Rodenas
Florence Rochat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43567734&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2545597(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec SA filed Critical Nestec SA
Application granted granted Critical
Publication of ES2545597T3 publication Critical patent/ES2545597T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Pediatric Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
ES10779417.4T 2009-11-12 2010-11-11 Composición nutritiva para fomentar el equilibrio de la flora intestinal y para fomentar la salud Active ES2545597T3 (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US260495P 2001-01-08
US26049509P 2009-11-12 2009-11-12
US26443009P 2009-11-25 2009-11-25
US264430P 2009-11-25
US39480510P 2010-10-20 2010-10-20
US394805P 2010-10-20
PCT/US2010/056321 WO2011060123A1 (en) 2009-11-12 2010-11-11 Nutritional composition for promoting gut microbiota balance and health

Publications (1)

Publication Number Publication Date
ES2545597T3 true ES2545597T3 (es) 2015-09-14

Family

ID=43567734

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10779417.4T Active ES2545597T3 (es) 2009-11-12 2010-11-11 Composición nutritiva para fomentar el equilibrio de la flora intestinal y para fomentar la salud

Country Status (14)

Country Link
US (2) US9192179B2 (enExample)
EP (1) EP2498626B1 (enExample)
JP (2) JP6006117B2 (enExample)
CN (2) CN102595934A (enExample)
AU (1) AU2010319490B2 (enExample)
BR (1) BR112012011294B1 (enExample)
CA (1) CA2777941C (enExample)
DK (1) DK2498626T3 (enExample)
ES (1) ES2545597T3 (enExample)
IN (1) IN2012DN03632A (enExample)
MX (1) MX336032B (enExample)
PH (1) PH12012500687A1 (enExample)
RU (1) RU2012123959A (enExample)
WO (1) WO2011060123A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2683014A1 (es) * 2017-03-23 2018-09-24 Cuetara, S.L. Galleta infantil sin azúcares añadidos

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12012500687A1 (en) * 2009-11-12 2012-10-29 Nestec Sa Nutritional composition for promoting gut microbiota balance and health
CA3167205A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
JP2014516589A (ja) 2011-06-20 2014-07-17 エイチ．ジェイ．ハインツ カンパニー プロバイオティック組成物及び方法（ｐｒｏｂｉｏｔｉｃｃｏｍｐｏｓｉｔｉｏｎａｎｄｍｅｔｈｏｄｓ）
WO2012175639A1 (en) * 2011-06-22 2012-12-27 Universite De Rouen Arabinogalactan proteins for use as an antiparasitic agent
FI126711B (fi) 2011-10-12 2017-04-13 Gut Guide Oy Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
CN103889241B (zh) 2011-10-18 2016-08-17 雀巢产品技术援助有限公司 用于促进健康的骨生长和/或用于预防和/或治疗骨疾病的组合物
TW201318566A (zh) * 2011-11-01 2013-05-16 呂健民 膳食補充劑組合物及其用於調控血糖之方法
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
ITRM20120084A1 (it) 2012-03-07 2013-09-08 Aboca Spa Societa Agricola Miscela prebiotica.
WO2014007606A1 (en) 2012-07-05 2014-01-09 N.V. Nutricia Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
US20150283144A1 (en) * 2012-11-01 2015-10-08 Rijksuniversiteit Groningen Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
WO2014082050A1 (en) 2012-11-23 2014-05-30 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
US20150296851A1 (en) * 2012-11-27 2015-10-22 Shanghai Jiao Tong University Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof
EP3904502A3 (en) 2013-02-04 2022-02-23 Seres Therapeutics, Inc. Compositions and methods
HK1218559A1 (zh) * 2013-02-04 2017-02-24 Seres Therapeutics, Inc. 抑制致病细菌生长的配方和方法
AU2014232370B2 (en) 2013-03-15 2018-11-01 Société des Produits Nestlé S.A. Network-based microbial compositions and methods
CN105555286A (zh) * 2013-03-15 2016-05-04 微生物治疗有限责任公司 活化的大豆豆荚纤维
GB201312713D0 (en) * 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
CA2945184A1 (en) * 2013-04-11 2014-10-16 Bright Drinks Inc. Compositions for prevention and/or treatment of gastrointestinal imbalances in digestive disorders
ITMI20131467A1 (it) * 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
CN116370507A (zh) 2013-11-25 2023-07-04 赛里斯治疗公司 协同细菌组合物以及其制造方法和用途
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
WO2015092056A1 (en) * 2013-12-20 2015-06-25 Nestec S.A. Nutritional compositions for reducing intestinal pathogens
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
CN104187624B (zh) * 2014-08-07 2016-06-08 逯明福 综合营养粉及其制备方法
WO2016029113A1 (en) * 2014-08-22 2016-02-25 Abbott Laboratories Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate
BR112017004630B1 (pt) 2014-09-30 2023-04-11 Kimberly-Clark Worldwide, Inc Formulação prebiótica sinérgica, lenço prebiótico, e, lenço umedecido prebiótico
BR112017004118B1 (pt) 2014-09-30 2022-04-12 Kimberly-Clark Worldwide, Inc Trama de papel crepado, produto de papel crepado de múltiplas camadas, e, método de fabricação de uma trama de papel crepado prebiótico
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
CN104432069A (zh) * 2014-12-22 2015-03-25 威海百合生物技术股份有限公司 一种肠胃通畅片
JP6338113B2 (ja) * 2015-03-31 2018-06-06 株式会社東洋新薬 除脂肪体重の増加剤
JP6861708B2 (ja) * 2015-12-30 2021-04-21 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 除脂肪体重を測定するための方法
JP2019501157A (ja) * 2015-12-31 2019-01-17 ネステク ソシエテ アノニム 口当たりを改善するための組成物
CA3011083A1 (en) * 2016-02-04 2017-08-10 Universiteit Gent Use of microbial communities for human and animal health
EP4302824A3 (en) 2016-04-20 2024-03-20 The Board of Trustees of the Leland Stanford Junior University Compositions and methods for nucleic acid expression and protein secretion in bacteroides
MA45327A (fr) 2016-05-13 2019-03-20 Sofar Spa Utilisation de probiotiques pour améliorer l'absorption des protéines
MA45288A (fr) 2016-06-08 2019-04-17 Sofar Spa Nouvelle utilisation médicale de probiotiques
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
CA3038061A1 (en) * 2016-09-22 2018-03-29 The University Of Chicago Immune response modulation using live biotherapeutics, for conditions such as allergy desensitization
IT201600122724A1 (it) 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
CA3048669A1 (en) 2016-12-15 2018-06-21 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating growth of a genetically modified gut bacterial cell
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
CN108245530A (zh) * 2016-12-28 2018-07-06 兰州奇正生态健康品有限公司 一种具有润肠通便作用的组合物及其制备方法与用途
RU2740156C1 (ru) 2017-06-21 2021-01-12 Эбботт Лабораториз Способы улучшения роста полезных бактерий в желудочно-кишечном тракте
RU2020110462A (ru) 2017-08-14 2021-09-16 Серес Терапеутикс, Инк. Композиции и способы для лечения холестатического заболевания
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
GB2566971B (en) * 2017-09-28 2020-12-02 Mjn Us Holdings Llc Infant formula having decreased protein content
IT201700108033A1 (it) 2017-09-27 2019-03-27 Neilos S R L Composizione per il trattamento della costipazione
IT201700108039A1 (it) 2017-09-27 2019-03-27 Neilos S R L Composizione per il trattamento della costipazione
EP3466276A1 (en) 2017-10-05 2019-04-10 Pharmactive Biotech Products, S.L. Dietary fiber composition for protecting bioactive compounds during the physiological digestion process
KR20200079292A (ko) 2017-10-30 2020-07-02 세레스 테라퓨틱스, 인코포레이티드 항생제 내성을 치료하기 위한 조성물 및 방법
EP3704958A4 (en) * 2017-10-31 2021-06-30 Morinaga Milk Industry Co., Ltd. MUSCLE BUILDING COMPOSITION
US11484547B2 (en) * 2018-01-08 2022-11-01 Performance Labs PTE. LTD. Compositions and methods for cholesterol, glucose and microbiome control
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
US20200113858A1 (en) 2018-10-15 2020-04-16 Freedom Health, Llc Human dietary supplement and method for treating digestive system and immune-related disorders
US12290545B2 (en) 2018-12-19 2025-05-06 Cosucra Groupe Warcoing S.A. Composition comprising chicory root and pea cell wall fiber for treating Brachyspira infections
CN113784630A (zh) * 2019-01-18 2021-12-10 Cp凯可美国公司 益生元组合物及其用途
WO2020161522A1 (en) * 2019-02-06 2020-08-13 Thd S.P.A. Fiber-based composition
FR3093427B1 (fr) * 2019-03-05 2021-03-05 Mativa Tech Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose
WO2020185857A1 (en) * 2019-03-12 2020-09-17 The Board Of Regents Of The University Of Texas System Simultaneous blood glucose monitoring and gastric emptying scintigraphy
CN109820865A (zh) * 2019-04-09 2019-05-31 福州大学 低聚木糖和部分水解的瓜尔豆胶复配组合物在预防肥胖及保健品中的应用
JP7321503B2 (ja) * 2019-05-21 2023-08-07 フジ日本精糖株式会社 イヌリンを含む筋肉量減少抑制又は骨密度減少抑制剤
CN114072013A (zh) 2019-05-29 2022-02-18 N·V·努特里奇亚 用于降低结肠蛋白发酵的非消化性寡糖
CN114377160A (zh) * 2019-07-09 2022-04-22 大连大学 一种落叶松阿拉伯半乳聚糖组合物的制备方法
HRP20250231T1 (hr) * 2019-08-30 2025-04-25 Hem Pharma Inc. Postupak za probiranje personalizirane supstance za poboljšanje crijevne flore uporabom pmas procesa
GB201915144D0 (en) * 2019-10-18 2019-12-04 Multigerm Uk Entpr Ltd Method of promoting SCFA production by gut microbiota
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
CN110679955A (zh) * 2019-11-11 2020-01-14 成都高新区九州华昀医疗美容门诊部有限公司 可改善肠道功能的大鲵活性肽营养组合物
US20230110977A1 (en) * 2020-02-27 2023-04-13 Abbott Laboratories Methods of improving bone health
BR112022019018A2 (pt) * 2020-04-24 2022-11-01 Nestle Sa Composição que compreende fibra e amora
CN111440841A (zh) * 2020-05-19 2020-07-24 爱礼康生物医药（苏州）有限公司 一种检测膳食纤维对人肠道菌活性影响的方法
WO2021233925A1 (en) * 2020-05-20 2021-11-25 Société des Produits Nestlé S.A. Beneficial effect of poaceae and/or leguminoseae fiber on survivability and metabolic activity of bifidobacterium longum
BR112022023331A2 (pt) * 2020-05-29 2022-12-20 Nestle Sa Composições e métodos para saúde digestiva em um animal
JP7688866B2 (ja) * 2020-07-14 2025-06-05 物産フードサイエンス株式会社 筋肉量率を増加させる剤および方法、ならびに体脂肪率を減少させる剤および方法
EP4231851A1 (en) * 2020-10-21 2023-08-30 Compagnie Gervais Danone Acacia gum for iron induced microbial dysbiosis
JP2022072243A (ja) * 2020-10-29 2022-05-17 帝人株式会社 腸内細菌叢改善用組成物及び腸内腐敗物質産生抑制用組成物
CN112715669A (zh) * 2020-11-24 2021-04-30 本溪木兰花乳业有限责任公司 一种改善便秘的牛奶制品及其制备方法
US20240058373A1 (en) 2020-12-09 2024-02-22 N.V. Nutricia Fibre mixture for young children
EP4119135A1 (fr) * 2021-07-13 2023-01-18 Luxia Scientific Methodes pour reequilibrer la flore intestinale chez les patients souffrant de la maladie de parkinson
WO2023288041A1 (en) * 2021-07-16 2023-01-19 Purdue Research Foundation Prebiotic composition and method of use to improve gastrointestinal health in patients with dysbiosis and leaky gut
CN113826892A (zh) * 2021-09-17 2021-12-24 潍坊易北特健康食品有限公司 一种基于肠道微生物调控特定胆汁酸的组合物及制备方法
WO2023054625A1 (ja) * 2021-09-29 2023-04-06 森永乳業株式会社 トレオン酸含有組成物及びその製造方法
JP2023055389A (ja) * 2021-10-06 2023-04-18 株式会社明治 バクテロイデス属細菌の増殖促進剤
CN114224925A (zh) * 2021-12-23 2022-03-25 广东格物生物科技有限公司 一种调节肠道健康的益生菌组合物及其制备方法
ES2955633A1 (es) * 2022-04-26 2023-12-04 Servicio Andaluz De Salud Composición para la rehabilitación intestinal
CN115025116B (zh) * 2022-07-13 2023-11-21 纽湃腾（北京）医药科技有限公司 一种显著改善胃食管反流伴肠易激综合征的组合物及其应用
WO2025106584A1 (en) * 2023-11-14 2025-05-22 Kate Farms, Inc. Infant formula
GR1011003B (el) * 2024-02-28 2025-07-22 Cloudpharm Private Company, Συμπληρωμα διατροφης για την αντιμετωπιση της απωλειας της οστικης πυκνοτητας (οστεοπενια)
WO2025262090A1 (en) * 2024-06-18 2025-12-26 Dsm Ip Assets B.V. Combination of carotenoids and inulin and uses thereof
CN121286706A (zh) * 2025-12-01 2026-01-09 仙乐健康科技股份有限公司 用于调整肠道菌群的组合物、营养组合物和用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952314A (en) 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
ES2123903T5 (es) 1995-08-04 2011-02-22 N.V. Nutricia Composición nutritiva conteniendo fibra.
ATE308254T1 (de) 1998-12-15 2005-11-15 Nestle Sa Ballaststoffemischung für enterale zusammensetzung
UA73763C2 (en) * 2000-03-01 2005-09-15 Nestle Sa Carbohydrate composition containing prebiotic for treatment or prevention of measles
EP1175905A1 (en) * 2000-07-24 2002-01-30 Societe Des Produits Nestle S.A. Nutritional Composition
US20020044988A1 (en) 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
ITMI20040956A1 (it) 2004-05-12 2004-08-12 Curti Alessandro Composizioni alimentari
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
PL1940248T3 (pl) 2005-10-05 2010-05-31 Nestec Sa Zastosowanie odżywczej formulacji do promowania doganiania wzrostu
ITMI20062031A1 (it) * 2006-10-23 2008-04-24 Velleja Res Srl Composizioni per la prevenzione del depauperamento della flora intestinale e del danno d'organo successivi a terapia antibiotica
CA2668613C (en) * 2006-11-07 2016-12-13 The Procter & Gamble Company Fiber containing compositions and methods of making and using same
ITMI20071214A1 (it) * 2007-06-15 2008-12-16 S I I T Srl Servizio Internazi Composizioni a base di componenti prebiotici ed immunogenici per la prevenzione e il trattamento di disturbi gastroenterici da disbiosi e/o alterazioni della normale flora intestinale
EP2178385B2 (en) 2007-07-18 2021-11-17 FrieslandCampina Nederland B.V. Heat stable nutritional beverage and method of preparing it
WO2009075564A1 (en) 2007-12-10 2009-06-18 N.V. Nutricia Paediatric fibre mixture
JP5992654B2 (ja) 2007-12-21 2016-09-14 ニュートリー株式会社 整腸及び／又は便通改善のための組成物
PH12012500687A1 (en) * 2009-11-12 2012-10-29 Nestec Sa Nutritional composition for promoting gut microbiota balance and health

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2683014A1 (es) * 2017-03-23 2018-09-24 Cuetara, S.L. Galleta infantil sin azúcares añadidos

Also Published As

Publication number Publication date
IN2012DN03632A (enExample) 2015-06-26
US20160100617A1 (en) 2016-04-14
CA2777941C (en) 2018-08-14
JP6205003B2 (ja) 2017-09-27
BR112012011294B1 (pt) 2018-03-20
EP2498626A1 (en) 2012-09-19
HK1172516A1 (en) 2013-04-26
EP2498626B1 (en) 2015-06-17
MX2012004778A (es) 2012-06-01
US20120269865A1 (en) 2012-10-25
JP2013510865A (ja) 2013-03-28
CA2777941A1 (en) 2011-05-19
BR112012011294A2 (pt) 2015-09-15
US9192179B2 (en) 2015-11-24
CN102595934A (zh) 2012-07-18
CN104206946A (zh) 2014-12-17
US10015978B2 (en) 2018-07-10
JP6006117B2 (ja) 2016-10-12
MX336032B (es) 2016-01-07
RU2012123959A (ru) 2013-12-20
PH12012500687A1 (en) 2012-10-29
WO2011060123A1 (en) 2011-05-19
JP2016166176A (ja) 2016-09-15
DK2498626T3 (en) 2015-07-13
AU2010319490B2 (en) 2015-03-19
AU2010319490A1 (en) 2012-05-03

Similar Documents

Publication Publication Date Title
ES2545597T3 (es) Composición nutritiva para fomentar el equilibrio de la flora intestinal y para fomentar la salud
JP5990241B2 (ja) 安定な増粘剤配合物
US6368617B1 (en) Dietary supplement
JP6133217B2 (ja) 食塊の安全な嚥下を促進するための伸長粘度
JP6034805B2 (ja) 高タンパク質栄養組成物並びにその製造方法及び使用方法
ES2625740T3 (es) Composiciones nutricionales que incluyen beta-hidroxi-beta-metilbutirato cálcico, fosfopéptido de caseina y proteina
TW200942228A (en) Oral or enteral composition useful for recovery of physical functions
CN103458889A (zh) 包括支链脂肪酸的用于创口愈合的营养组合物
JP2014512372A (ja) α−ＨＩＣＡ及びエイコサペンタエン酸を含有する栄養組成物
JP2013529193A (ja) 非経口栄養から経腸栄養へ離脱させるための栄養組成物及び方法
JP2015501649A (ja) 食塊の安全な嚥下を促進するための伸長粘度
Wang et al. Reinventing gut health: leveraging dietary bioactive compounds for the prevention and treatment of diseases
WO2014148881A1 (es) Mezcla gelatinosa de probióticos y prebióticos con acción simbiótica sinérgica para el tratamiento de enfermedad renal crónica
CN102264380A (zh) 低浓度的营养组合物
JP2013505720A (ja) テアニン及び外因性ヌクレオチドを含む栄養組成物
DK175877B1 (da) Præparater til anvendelse som terapeutisk middel
ES2674874T3 (es) Composición antiinflamatoria
CN103945835A (zh) 一种组合物以及应用l-阿拉伯糖及选择性化合物的方法
CN112401246A (zh) 一种补气、益肾、抗疲劳的液体饮料及其制备方法
Laya et al. Food Bioactives in the Prevention and Clinical Management of Obesity
ES2770796T3 (es) Viscosidad extensional para favorecer una deglución segura de los bolos alimenticios
WO2024043774A1 (es) Bebida de jamaica ( hibiscus sabdariffa) con alta concentración de antioxidantes y fibra dietética y proceso de obtención
IT202300008874A1 (it) Associazione flavonoica biodisponibile a base di flavonoidi e almeno un estratto vegetale comprendente saponine per il trattamento della disfunzione erettile
ES2870568T3 (es) Productos nutricionales para fomentar una deglución segura para individuos con disfagia
WO2024138281A1 (es) Composición nutracéutica de harina de bagazo de uva (hbu) alta en fibra, dispersable en agua